Results 111 to 120 of about 47,001 (202)

Polyarticular arthritis as presenting feature of farber disease: a lysosomal storage disease involving inflammation [PDF]

Pediatr Rheumatol Online J, 2014
Sólyom A, Karabul N, Hügle B, Simonaro C, Schuchman E.   +4 more
europepmc   +1 more source

Farber's disease.

Indian pediatrics, 1992
P D, Singhi, P, Padmini, S B, Mantri
openaire   +1 more source

Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy. [PDF]

Oncologist
Murchison K, Khaddour K, Camargo A, Ruiz E, Sethi R, Rettig E, Yoon C, Kim EY, DeSimone M, Cohen J, LeBoeuf NR, Ran N, Thakuria M, Silk AW.   +13 more
europepmc   +1 more source

Farber Disease - A Case Report

Journal of Medical Science And clinical Research, 2020
openaire   +1 more source

Farber Disease Misdiagnosed as Hemangioendothelioma

Journal of the Korean Association of Pediatric Surgeons, 2016
Sang Mok Lee, Chaeyoun Oh, Sung-Eun Jung, Hyun-Young Kim   +3 more
openaire   +1 more source

Tumor genomic landscape of older patients with metastatic breast cancer^☆. [PDF]

ESMO Open
Gupta H, Brantley KD, Grinda T, Freedman RA, Kodali A, Kirkner GJ, Hughes ME, Higgins A, Newman AB, Avdulla S, Files J, Suggs G, Tolaney SM, Dillon D, Sholl L, Garrido-Castro AC, Cherniack AD, Lin NU.   +17 more
europepmc   +1 more source

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL. [PDF]

Blood Adv
Crombie JL, Ahn IE, Ren Y, Tyekucheva S, Carey C, Kniezewski M, Normilus S, Solomon S, Montegaard J, Kim AI, Merryman RW, Armand P, Fisher DC, Brown JR, Davids MS.   +14 more
europepmc   +1 more source

Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies. [PDF]

JNCI Cancer Spectr
Morganti S, Kim SE, Jin Q, Cha J, Zeigler JE, Newman AB, Kirkner GJ, Snow C, Zheng Y, Vincuilla J, Parker T, Buehler RM, Bychkovsky BL, Dibble KE, Sella T, Ruddy KJ, Rosenberg SM, Collins LC, Peppercorn J, Schapira L, Borges VF, Guzman-Arocho YD, Come SE, Warner E, Poorvu PD, Lambertini M, Curigliano G, Hughes ME, Mittendorf EA, King TA, Lin NU, Garber JE, Tayob N, Tolaney SM, Partridge AH, Lynce F.   +35 more
europepmc   +1 more source

Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma. [PDF]

Neuro Oncol
Groves A, Kirkland OO, Lo Cascio C, Wang X, Heaslip C, Graca Marques J, Song C, Poetschke R, Wang T, Chin DH, Asante Y, Liu Q, Kim H, Gu S, Trissal M, Labelle J, Veiga Cruzeiro GA, Jones KL, Cameron AB, Clark LM, Leeper B, Nguyen QD, Gryder BE, Filbin MG, Qi J.   +24 more
europepmc   +1 more source